Tech On Drugs - Episode 4 - Dr. Emanuele de Rinaldis, Sanofi
Regístrate gratis
Escucha este episodio y muchos más. ¡Disfruta de los mejores podcasts en Spreaker!
Descarga y escucha en cualquier lugar
Descarga tus episodios favoritos y disfrútalos, ¡dondequiera que estés! Regístrate o inicia sesión ahora para acceder a la escucha sin conexión.
Descripción
What will the future of precision medicine look like 5-10 years down the line? And how will AI accelerate this future? I asked Dr. Emanuele de Rinaldis to answer this...
mostra másI asked Dr. Emanuele de Rinaldis to answer this and many other questions.
Emanuele is VP, Global Head of Precision Medicine & Computational Biology at Sanofi R&D.
He believes that AI will help us define new taxonomies of diseases. We will identify different types of Asthma, different types of Fibrosis.
And AI will help us create a new textbook – not one driven by just clinical observations, but a textbook driven by genetics and gene expression, together with real world evidence.
This will take drug development and precision medicine to a level we have never seen before.
Información
Autor | CytoReason |
Organización | Yoav Schumacher |
Página web | - |
Etiquetas |
-
|
Copyright 2024 - Spreaker Inc. an iHeartMedia Company